-
3-[(benzylsulfanyl)methyl]-6-chloro-1,1-dioxo-4H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
-
ChemBase ID:
444
-
Molecular Formular:
C15H14ClN3O4S3
-
Molecular Mass:
431.93736
-
Monoisotopic Mass:
430.98349662
-
SMILES and InChIs
SMILES:
Clc1c(S(=O)(=O)N)cc2S(=O)(=O)N=C(Nc2c1)CSCc1ccccc1
Canonical SMILES:
Clc1cc2NC(=NS(=O)(=O)c2cc1S(=O)(=O)N)CSCc1ccccc1
InChI:
InChI=1S/C15H14ClN3O4S3/c16-11-6-12-14(7-13(11)25(17,20)21)26(22,23)19-15(18-12)9-24-8-10-4-2-1-3-5-10/h1-7H,8-9H2,(H,18,19)(H2,17,20,21)
InChIKey:
NDTSRXAMMQDVSW-UHFFFAOYSA-N
-
Cite this record
CBID:444 http://www.chembase.cn/molecule-444.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
3-[(benzylsulfanyl)methyl]-6-chloro-1,1-dioxo-4H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
|
3-[(benzylsulfanyl)methyl]-6-chloro-1,1-dioxo-4H-1λ6,2,4-benzothiadiazine-7-sulfonamide
|
|
|
IUPAC Traditional name
|
|
Brand Name
|
Aquatag
|
Benzothiazide
|
Benzthazide
|
Dihydrex
|
Diucen
|
Edemex
|
Exna
|
Exosalt
|
Fovane
|
Freeuril
|
Hydrine
|
Lemazide
|
Naclex
|
Pfizer 1393
|
Proaqua
|
Urese
|
|
|
Synonyms
|
Benzthiazide
|
6-Chloro-3-[[(phenylmethyl)thio]methyl]-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-Dioxide
|
3-[(Benzylthio)methyl]-6-chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-Dioxide
|
Aquatag
|
Benzothiazide
|
Dihydrex
|
Diucen
|
Diucene
|
Edemex
|
ExNa
|
Exosalt
|
Fovane
|
Freeuril
|
HyDrine
|
Lemazide
|
P 1393
|
Pfizer 1393
|
Proaqua
|
Regulon
|
Urese
|
|
|
CAS Number
|
|
PubChem SID
|
|
PubChem CID
|
|
CHEBI ID
|
|
CHEMBL
|
|
Chemspider ID
|
|
DrugBank ID
|
|
KEGG ID
|
|
Unique Ingredient Identifier
|
|
Wikipedia Title
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
Data Source
|
Data ID
|
Price
|
TRC
|
|
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
ALOGPS 2.1
Acid pKa
|
8.766833
|
H Acceptors
|
6
|
H Donor
|
2
|
LogD (pH = 5.5)
|
1.8404658
|
LogD (pH = 7.4)
|
1.8236142
|
Log P
|
1.840787
|
Molar Refractivity
|
104.1407 cm3
|
Polarizability
|
41.080338 Å3
|
Polar Surface Area
|
118.69 Å2
|
Rotatable Bonds
|
5
|
Lipinski's Rule of Five
|
true
|
Log P
|
2.26
|
LOG S
|
-4.53
|
Solubility (Water)
|
1.29e-02 g/l
|
DETAILS
DETAILS
DrugBank
Wikipedia
TRC
DrugBank -
DB00562
|
Item |
Information |
Drug Groups
|
approved |
Description
|
Benzthiazide is used to treat hypertension and edema. Like other thiazides, benzthiazide promotes water loss from the body (diuretics). They inhibit Na+/Cl- reabsorption from the distal convoluted tubules in the kidneys. Thiazides also cause loss of potassium and an increase in serum uric acid. Thiazides are often used to treat hypertension, but their hypotensive effects are not necessarily due to their diuretic activity. Thiazides have been shown to prevent hypertension-related morbidity and mortality although the mechanism is not fully understood. Thiazides cause vasodilation by activating calcium-activated potassium channels (large conductance) in vascular smooth muscles and inhibiting various carbonic anhydrases in vascular tissue. |
Indication |
For the treatment of high blood pressure and management of edema. |
Pharmacology |
Benzthiazide is used to treat hypertension and edema. Like other thiazides, benzthiazide promotes water loss from the body (diuretics). They inhibit Na+/Cl- reabsorption from the distal convoluted tubules in the kidneys. Thiazides also cause loss of potassium and an increase in serum uric acid. Thiazides are often used to treat hypertension, but their hypotensive effects are not necessarily due to their diuretic activity. Thiazides have been shown to prevent hypertension-related morbidity and mortality although the mechanism is not fully understood. Thiazides cause vasodilation by activating calcium-activated potassium channels (large conductance) in vascular smooth muscles and inhibiting various carbonic anhydrases in vascular tissue. |
Toxicity |
Symptoms of overdose include nausea, vomiting, fatigue, urinary problems and drowsiness. |
Affected Organisms |
• |
Humans and other mammals |
|
Absorption |
Absorbed in the digestive tract. |
Protein Binding |
30% |
|
PATENTS
PATENTS
PubChem Patent
Google Patent